Advertisement
Screener

STREAMEX CORP. (STEX) Proceeds from Stock Options Exercised

2.8 / 5 stars · 68/120 Roast Me

STREAMEX CORP. Proceeds from Stock Options Exercised

STREAMEX CORP. (STEX) reported Proceeds from Stock Options Exercised of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-03-31

  • STREAMEX CORP. proceeds from stock options exercised for the quarter ending 2021-12-31 was $0.00.
  • STREAMEX CORP. proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
  • STREAMEX CORP. proceeds from stock options exercised for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
  • STREAMEX CORP. proceeds from stock options exercised for the quarter ending 2021-03-31 was $28.00K.
  • STREAMEX CORP. proceeds from stock options exercised for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
  • STREAMEX CORP. proceeds from stock options exercised for fiscal 2021 was $28.00K, a 98.97% decline from fiscal 2020.
  • STREAMEX CORP. proceeds from stock options exercised for fiscal 2020 was $2.72M, a 190.19% increase from fiscal 2019.
  • STREAMEX CORP. proceeds from stock options exercised for fiscal 2019 was $938.00K, a 52.37% increase from fiscal 2018.
Period endProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 6 month as first filedProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 9 month as first filedProceeds from Stock Options Exercised 12 monthProceeds from Stock Options Exercised 12 month as first filed
2022-12-31$0.00
10-K · filed 2023-03-31
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$0.00
derived: sum of 2 quarters · filed 2023-03-31
$0.00
derived: sum of 3 quarters · filed 2023-03-31
$28.00K
10-K · filed 2023-03-31
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$0.00
derived: sum of 2 quarters · filed 2021-11-15
$28.00K
10-Q · filed 2021-11-15
$28.00K
derived: sum of 4 quarters · filed 2022-03-31
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$28.00K
10-Q · filed 2021-08-11
$28.00K
derived: sum of 3 quarters · filed 2022-03-31
$520.53K
derived: sum of 4 quarters · filed 2022-03-31
2021-03-31$28.00K
10-Q · filed 2021-05-17
$28.00K
derived: sum of 2 quarters · filed 2022-03-31
$520.53K
derived: sum of 3 quarters · filed 2022-03-31
$2.75M
derived: sum of 4 quarters · filed 2022-03-31
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$492.53K
derived: sum of 2 quarters · filed 2022-03-31
$2.72M
derived: sum of 3 quarters · filed 2022-03-31
$2.72M
10-K · filed 2022-03-31
2020-09-30$492.53K
10-Q · filed 2020-11-05
$2.72M
derived: sum of 2 quarters · filed 2020-11-05
$2.72M
10-Q · filed 2021-11-15
$2.72M
10-Q · filed 2020-11-05
$3.19M
derived: sum of 4 quarters · filed 2021-05-17
2020-06-30$2.23M
10-Q · filed 2020-08-06
$2.23M
10-Q · filed 2021-08-11
$2.23M
10-Q · filed 2020-08-06
$2.70M
derived: sum of 3 quarters · filed 2021-05-17
$2.72M
derived: sum of 4 quarters · filed 2021-05-17
2020-03-31$0.00
10-Q · filed 2021-05-17
$472.80K
derived: sum of 2 quarters · filed 2021-05-17
$493.16K
derived: sum of 3 quarters · filed 2021-05-17
$938.00K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$472.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
$493.16K
derived: sum of 2 quarters · filed 2021-03-15
$938.00K
derived: sum of 3 quarters · filed 2021-03-15
$938.00K
10-K · filed 2021-03-15
$938.03K
10-K · filed 2020-03-13
2019-09-30$20.36K
10-Q · filed 2020-11-05
$465.20K
derived: sum of 2 quarters · filed 2020-11-05
$465.20K
10-Q · filed 2020-11-05
$1.92M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$444.84K
10-Q · filed 2020-08-06
$444.84K
10-Q · filed 2020-08-06
$1.90M
derived: sum of 3 quarters · filed 2020-08-06
$2.52M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$1.46M
10-Q · filed 2019-04-15
$1.46M
derived: sum of 2 quarters · filed 2020-03-13
$2.08M
derived: sum of 3 quarters · filed 2020-03-13
$2.08M
derived: sum of 4 quarters · filed 2020-03-13
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$615.60K
derived: sum of 2 quarters · filed 2020-03-13
$615.60K
derived: sum of 3 quarters · filed 2020-03-13
$615.60K
10-K · filed 2020-03-13
2018-09-30$615.60K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23
$615.60K
derived: sum of 2 quarters · filed 2019-10-23
$615.60K
10-Q · filed 2019-10-23
$615.60K
derived: sum of 4 quarters · filed 2019-10-23
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$0.00
10-Q · filed 2019-07-31
$0.00
derived: sum of 3 quarters · filed 2019-07-31
2018-03-31$0.00
10-Q · filed 2019-04-15
$0.00
derived: sum of 2 quarters · filed 2019-04-15
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$0.00
10-K · filed 2019-03-15
2017-09-30$0.00
10-Q · filed 2018-11-02
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11
$0.00
derived: sum of 2 quarters · filed 2017-04-11
$0.00
10-K · filed 2017-04-11
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
2016-06-30$0.00
10-Q · filed 2016-08-12
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11
$0.00
derived: sum of 2 quarters · filed 2017-04-11
$20.90K
10-K · filed 2017-04-11
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$20.90K
10-Q · filed 2016-11-14
2015-06-30$20.90K
10-Q · filed 2016-08-12
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
$0.00
derived: sum of 2 quarters · filed 2016-03-14
$0.00
10-K · filed 2016-03-14
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$0.00
10-Q · filed 2015-11-13
2014-06-30$0.00
10-Q · filed 2015-07-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B